Paolo Tarantino: In our latest The Oncologist article led by Edoardo Crimini, we analyze geographical accessibility to NGS-informed trials in Italy

Paolo Tarantino, MD, Clinical research fellow at the Dana-Farber Cancer Institute, shared the following insight on  X/Twitter:

“NGS allows to match patients to trials, but only if these are accessible. In our latest The Oncologist article led by Edoardo Crimini, we analyze geographical accessibility to NGS-informed trials in Italy, finding heterogeneous availability, but a trend toward improvement.”

For the article click here.
Source: Paolo Tarantino/Twitter